Clinical Trial Update: Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports results on coadministering a live attenuated Japanese encephalitis vaccine with a measles vaccine in 9-month-old infants. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis
• Measles

Drugs mentioned

• Live attenuated Japanese encephalitis vaccine (Japanese encephalitis vaccine (live attenuated))
• Measles vaccine (Measles vaccine)

Snippet

Sponsor: PATH | Conditions: Japanese Encephalitis | Phase 4 | Status: COMPLETED | Results posted: 2019-02-08